April 12, 2021
RegMed Investors’ (RMi) pre-open: caution is in the air as the trend indicator beguiles
April 9, 2021
RegMed Investors’ (RMi) pre-open: trust, confidence versus conviction
April 8, 2021
RegMed Investors’ (RMi) pre-open: how now brown cow?
April 7, 2021
RegMed Investors’ (RMi) pre-open: share pricing exhibits a streaking on the field anticipating a tackling
April 6, 2021
RegMed Investors’ (RMi) pre-open: what’s normal in this market?
April 5, 2021
RegMed Investors’ (RMi) pre-open: what and where will the demand for increased share pricing come from?
April 1, 2021
RegMed Investors’ (RMi) pre-open: Q2 begins as holiday closes in
March 31, 2021
RegMed Investors’ (RMi) pre-open: a mixed bag, strength is a mixed bag to sell into
March 30, 2021
RegMed Investors’ (RMi) pre-open: countdown – 2 sessions and the month/quarter closes
March 29, 2021
RegMed Investors’ (RMi) pre-open: deal after reshuffling the deck with two (2) sessions left in month and quarter
March 26, 2021
RegMed Investors’ (RMi) pre-open: TGIF, strength is migratory and the cell and gene therapy sector seems directionless
March 25, 2021
RegMed Investors’ (RMi) pre-open: bottom-fishing in a small pond and maybe watching a knife fall
March 23, 2021
RegMed Investors’ (RMi) pre-open: the beat-down goes on after one crash, another Q4 loss with merger ups risk paradigm
March 19, 2021
RegMed Investors’ (RMi) pre-open: welcome to Friday and a bounce back
March 18, 2021
RegMed Investors’ (RMi) pre-open: drops in futures scare me
March 17, 2021
RegMed Investors’ (RMi) pre-open: waiting for Powell is like sitting next to Godot on the bench
March 16, 2021
RegMed Investors’ (RMi) pre-open: whack-a-mole
March 15, 2021
RegMed Investors’ (RMi) pre-open: sector hovers as markets expect discontent from Fed meeting
March 12, 2021
RegMed Investors’ (RMi) pre-open: ra, ra, the fiscal aid/stimulus; euphoria but, prepare for the headwind
March 11, 2021
RegMed Investors’ (RMi) pre-open: coming off last night's half-filled glass
March 10, 2021
RegMed Investors’ (RMi) pre-open: hanging in or getting out
March 9, 2021
RegMed Investors’ (RMi) pre-open: BUY opportunities post sell-off
March 8, 2021
RegMed Investors’ (RMi) pre-open: the sector is still rotating with a slightly slippery slope
47 min ago
RMi Closing Bell: Cell and gene therapy sector bounds
9 hours 16 min ago
RMi Pre-opening: Recoil, ricochet with a cold shiver
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.